In-Silico Evaluation of Binding Interaction and ADME Properties of Novel Pyrazoline and Pyrimidine Derivatives Targeting Cyclooxygenase-2 Enzyme
DOI:
https://doi.org/10.32947/ajps.v25i1.1148Keywords:
Anti-inflammatory, cyclooxygenase, Molecular Docking, Pyrazoline, PyrimidineAbstract
Inflammation is a crucial defense mechanism against toxic stimuli and physical traumas. This study aimed to design six new pyrazoline and pyrimidine derivatives and assess their potential anti-inflammatory activity by targeting the cyclooxygenase (COX) enzyme, a key mediator in the inflammation process. Through in-silico methods, the binding affinity of these derivatives to the COX-2 receptor was predicted using computer simulations and compared with the reference drug, meloxicam.
Docking studies employing gold software facilitated the visualization of ligand-protein interactions, utilizing the crystal structure of the COX-2 protein (PDB ID: 4m11). Preceding the docking procedure, the receptor underwent energy minimization by SPDPV software and hydrogen atoms addition. Compounds 1 to 6 exhibited superior docking scores, indicative of strong binding affinities and favorable positioning within the COX-2 enzyme's active site. The results of using this approach are series of products content of pyrazoline and pyrimidine derivatives that had greater potency as anti-inflammatory action and binding in the active location inside the COX-2 protein may potentially serve as a lead for the identification of novel anti-inflammatory medications to decrease the side effects and toxicity that produced from some NSAIDs.
References
1- Amagon KI, Falang KD, Bukar BB, Ajima U, Wannang NN, Kolawole JA, et al. Anti-nociceptive and anti-inflammatory effects of the hydroethanolic extract of a polyherbal preparation (Cov-Pla 2) in laboratory animals. Journal of Pharmacy & Bioresources 2021;17(2):81–7.
2- Sandhya Professor R, Rajeshkumar S. ANTIINFLAMMATORY ACTIVITY OF FISCUS BENGHALENSIS AND AZADIRACHTA INDICA FORMULATION-AN INVITRO STUDY. 2:2023.
3- Serhan CN. Treating inflammation and infection in the 21st century: New hints from decoding resolution mediators and mechanisms. FASEB Journal2017;31(4):1273–88.
4- Abdull MT, Mahdi MF, Khan AK. AJPS (2023) 336. 2023.
5- Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, et al. Chronic inflammation in the etiology of disease across the life span. Nat Med 2019;25(12):1822–32.
6- Gupta A, Bah M. NSAIDs in the Treatment of Postoperative Pain. Curr Pain Headache Rep2016;20(11).
7- Rashid H ur, Martines MAU, Duarte AP, Jorge J, Rasool S, Muhammad R, et al. Research developments in the syntheses, anti-inflammatory activities and structure-activity relationships of pyrimidines. RSC Adv 2021;11(11):6060–98.
8- Giménez-Bastida JA, González-Sarrías A, Espín JC, Schneider C. Inhibition of 5-Lipoxygenase-Derived Leukotrienes and Hemiketals as a Novel Anti-Inflammatory Mechanism of Urolithins. Mol Nutr Food Res 2020;64(11).
9- Rashid H ur, Martines MAU, Duarte AP, Jorge J, Rasool S, Muhammad R, et al. Research developments in the syntheses, anti-inflammatory activities and structure-activity relationships of pyrimidines. RSC Adv 2021;11(11):6060–98.
10- Dvorakova M, Landa P. Anti-inflammatory activity of natural stilbenoids: A review. Pharmacol Res2017; 124:126–45.
11- Priya D, Gopinath P, Dhivya LS, Vijaybabu A, Haritha M, Palaniappan S, et al. Structural Insights into Pyrazoles as Agents against Anti-inflammatory and Related Disorders. ChemistrySelect2022;7(5).
12- Straus DS, Glass CK. Cyclopentenone Prostaglandins: New Insights on Biological Activities and CellularTargets. John Wiley & Sons, Inc; 2001.
13- Sharma S, Kumar D, Singh G, Monga V, Kumar B. Recent advancements in the development of heterocyclic anti-inflammatory agents. Eur J Med Chem2020;200.
14- Ahmadi M, Bekeschus S, Weltmann KD, von Woedtke T, Wende K. Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors. RSC Med Chem2022;
15- Bacchi S, Palumbo P, Sponta A, Coppolino MF. Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A Review. Antiinflamm Antiallergy Agents Med Chem 2012;11(1):52–64.
16- Khan S, Andrews KL, Chin-Dusting JPF. Cyclo-oxygenase (COX) inhibitors and cardiovascular risk: Are non-steroidal anti-inflammatory drugs really anti-inflammatory? Int J Mol Sci2019;20(17).
17- Dreischulte T, Morales DR, Bell S, Guthrie B. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney Int 2015;88(2):396–403.
18- Becker JC, Domschke W, Pohle T. Current approaches to prevent NSAID-induced gastropathy - COX selectivity and beyond. In: British Journal of Clinical Pharmacology. 2004. page 587–600.
19- Kumar Vishwakarma R, Negi DS. THE DEVELOPMENT OF COX-1 AND COX-2 INHIBITORS: A REVIEW Isolation and synthesis of natural compound for their medicinal value evaluation View project THE DEVELOPMENT OF COX-1 AND COX-2 INHIBITORS: A REVIEW. Int J Pharm Sci Res [Internet] 2020;11(8):3544. Available from: http://dx.doi.org/10.13040/IJPSR.0975-8232.11
20- Arfè A, Scotti L, Varas-Lorenzo C, Nicotra F, Zambon A, Kollhorst B, et al. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ 2016;354:i4857.
21- Kerru N, Gummidi L, Maddila S, Gangu KK, Jonnalagadda SB. A review on recent advances in nitrogen-containing molecules and their biological applications. Molecules2020;25(8).
22- Dash B, Karim S. PYRAZOLINE HETEROCYCLIC: A REVIEW Synthesis and antimicrobial screening of pyrazoline derivatives View project Review of Pyrazoline heterocycle View project PYRAZOLINE HETEROCYCLIC: A REVIEW. Article in International Journal of Pharmaceutical Sciences and Research [Internet] 2021;12(5):2570. Available from: http://dx.doi.org/10.13040/IJPSR.0975-8232.12
23- Holota S, Derkach H, Demchuk IL, Vynnytska RB, Antoniv OI, Furdychko LO, et al. Synthesis and In vivo evaluation of pyrazoline-thiazolidin-4-one hybrid Les-5581 as a potential non-steroidal anti-inflammatory agent. Biopolym Cell 2019;35(6):437–47.
24- document (11).
25- Salian V V., Narayana B, Sarojini BK, Byrappa K. A Comprehensive Review on Recent Developments in the Field of Biological Applications of Potent Pyrazolines Derived from Chalcone Precursors. Lett Drug Des Discov 2018;15(5):516–74.
26- Trivedi AR, Dodiya DK, Ravat NR, Shah VH. Synthesis and biological evaluation of some new pyrimidines via a novel chalcone series. General Papers ARKIVOC 2008;131–41.
27- Alfayomy AM, Abdel-Aziz SA, Marzouk AA, Shaykoon MSA, Narumi A, Konno H, et al. Design and synthesis of pyrimidine-5-carbonitrile hybrids as COX-2 inhibitors: Anti-inflammatory activity, ulcerogenic liability, histopathological and docking studies. Bioorg Chem 2021;108.
28- Cobanoglu MC, Liu C, Hu F, Oltvai ZN, Bahar I. Predicting drug-target interactions using probabilistic matrix factorization. J Chem Inf Model 2013;53(12):3399–409.
29- Yousif OA, Mahdi MF, Raauf AMR. Design, synthesis, preliminary pharmacological evaluation, molecular docking and ADME studies of some new pyrazoline, isoxazoline and pyrimidine derivatives bearing nabumetone moiety targeting cyclooxygenase enzyme. Journal of Contemporary Medical Sciences 2019;5(1):41–50.
30- Vincent S, Arokiyaraj S, Saravanan M, Dhanraj M. Molecular Docking Studies on the Anti-viral Effects of Compounds From Kabasura Kudineer on SARS-CoV-2 3CLpro. Front Mol Biosci 2020;7.
31- Abdulredha FH, Mahdi MF, Khan AK. In silico molecular docking, ADME study and synthesis of new 1,3-diazetidin-2-one derivatives with high anti-proliferative activity. F1000Res 2023; 12:1090.
32- Saleem Ameen DM. Synthesis A New Bis Oxazine and Thiazine Derivatives and Study Their Biological Activitiesـــ [Internet]. 2022. Available from: https://orcid.org/0000-0003--1067-1847
33- Daina A, Michielin O, Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7.
34- Mohamed A, Tharik S, Meyyanathan SN. Swiss ADME predictions for anti cancer drug molecules prior In Vitro In Vivo Correlations (IVIVC) [Internet]. Available from: http://xisdxjxsu.asia
35- Huang SY, Zou X. Ensemble docking of multiple protein structures: Considering protein structural variations in molecular docking. Proteins: Structure, Function and Genetics 2007;66(2):399–421.
36- Prokopenko YS, Perekhoda LO, Georgiyants VA. Docking studies of biologically active substances from plant extracts with anticonvulsant activity. J Appl Pharm Sci 2019;9(1):66–72.
37- Mahesh G, Kumar KA, Reddanna P. Overview on the discovery and development of anti-inflammatory drugs: Should the focus be on synthesis or degradation of pge2? J Inflamm Res 2021;14:253–63.
38- Klebe G. Virtual ligand screening: strategies, perspectives and limitations. Drug Discov Today2006;11(13–14):580–94.
39- Oashi T, Ringer AL, Raman EP, MacKerell AD. Automated selection of compounds with physicochemical properties to maximize bioavailability and druglikeness. J Chem Inf Model 2011;51(1):148–58.
40- Khudhair MA, Mahdi MF, Khan AK, Abd Razik BM. Molecular modeling, drug design and binding evaluation of new oxazole derivatives as cyclooxygenase inhibitors. Egypt J Chem 2021;64(9):5101–9.
41- Chy MNU, Adnan M, Rauniyar AK, Amin MM, Majumder M, Islam MS, et al. Evaluation of anti-nociceptive and anti-inflammatory activities of Piper sylvaticum (Roxb.) stem by experimental and computational approaches. Orient Pharm Exp Med 2019;
42- Salih T, Salih HA. In Silico Design and Molecular Docking Studies of Carbapenem Analogues Targeting Acinetobacter baumannii PBP1A Receptor.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Sarmad Abbas Fadhil, Karima Fadhil Ali, Wesen Adel Mehde
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
